Study on Systemic Sclerosis Progression
Cohort of Patients With Systemic Sclerosis Within the Framework of the RESO Reference Centre
Recruiting
N/A
Interventional Study
Scleroderma
Systemic Sclerosis
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Other
- Participants needed
- 500 (estimated)
- Sponsor
- University Hospital, Bordeaux · Other
Who this trial is looking for
This trial is looking for adult patients with systemic sclerosis or very early systemic sclerosis. Participants will be followed over 5 years to understand how the condition progresses.
Are You a Good Fit for This Trial?
You may be able to join if
- I am over 18 years old.
- I have been diagnosed with systemic scleroderma.
- I have very early systemic sclerosis with Raynaud's phenomenon.
- I am affiliated with a social security scheme.
- I have given my written consent to participate.
You may not be able to join if
- I am pregnant.
- I am breastfeeding.
- I am under legal protection such as guardianship.
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Systemic sclerosis (SSc) is a rare form of connective tissue disease characterized by vascular involvement and the intensity of fibrosis. The lack of available treatment is largely due to the very fragmented understanding of the pathophysiology of SSc. However, one of the keys to conducting quality research on this disease remains the development of well-documented patient cohorts with reliable bi…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Patient over 18 years old
* Patient with systemic scleroderma according to the ACR/EULAR 2013 criteria, or with a " very early systemic sclerosis " defined by the presence of Raynaud's phenomenon and auto-antibodies in blood sample (ACAN positivity (≥1/160) with anti-Scl70, an…
Contacts